FDA & DEA Regulation of Opioid Drugs & Crisis 2022 - McDermott Skip to main content

FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022

FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022

Overview


Brian Malkin joins the DC Bar for their event, “FDA and DEA Regulation of Opioid Drugs and the Opioid Crisis 2022.” Brian and panel will cover, the regulation of opioid drugs and the legal issues involved in combating this crisis in the United States. The panel will also discuss how the US Drug Enforcement Administration (DEA) schedules opioid drugs and develops annual quotas and prevents diversion, and how pain and substance abuse treatment doctors from the American Medical Association’s perspective view these important regulatory issues and interact with the regulators at the FDA and DEA.

Learn more and register here.

Dig Deeper

Webinar / Speaking Engagements / January 22, 2026

HIPAA Compliance for Medical Device Companies in the AI Age

San Francisco, CA / In-person / January 13, 2026

McDermott Forum at the 2026 J.P. Morgan Healthcare Conference

Dallas, TX / In-person / December 4, 2025

Health Innovators Holiday Celebration 2025

Dallas, TX / In-person / November 20, 2025

BIO BREAK: Dallas’ Monthly Life Sciences Happy Hour

Boston, MA / In-person / November 13, 2025

Life Sciences Investment Forum 2025